1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Zdunek, J.
Martinez, G.V.
Schleucher, J.
Lycksell, P.O.
Yin, Y.
Nilsson, S.
Shen, Y.
Olivecrona, G.
Wijmenga, S.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
42
1872
10.1021/BI0267184
12590574
Global Structure and Dynamics of Human Apolipoprotein Cii in Complex with Micelles: Evidence for Increased Mobility of the Helix Involved in the Activation of Lipoprotein Lipase
2003
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
8921.864
APOLIPOPROTEIN C-II
1
man
polymer
APO-CII
no
no
TQQPQQDEMPSPTFLTQVKESLSSYWESAKTAAQNLYEKTYLPAVDEKLRDLYSKSTAAMSTYTGIFTDQVLSVLKGEE
TQQPQQDEMPSPTFLTQVKESLSSYWESAKTAAQNLYEKTYLPAVDEKLRDLYSKSTAAMSTYTGIFTDQVLSVLKGEE
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
HUMAN
sample
9606
LIVER
HOMO SAPIENS
469008
ESCHERICHIA COLI
BL21(DE3)
PET29A(+)
PET29A-HAPOCII
repository
Initial release
Version format compliance
Version format compliance
1
0
2003-02-27
1
1
2011-05-08
1
2
2011-07-13
PEPTIDE OF HUMAN APOLIPOPROTEIN C-II
NMR STRUCTURE OF HUMAN APOLIPOPROTEIN C-II IN THE PRESENCE OF SDS
HELIX
DETERMINATION METHOD: AUTHOR PROVIDED.
PDBE
Y
PDBE
2002-11-29
REL
APOC-II IS A COMPONENT OF THE VERY LOW DENSITY
LIPOPROTEIN (VLDL) FUNCTIONS AS AN ACTIVATOR OF
SEVERAL TRIACYLGLYCEROL LIPASES.
LEAST ENERGY, LEAST RESTRAINT VIOLATION
100
68
CBCANHCBCA(CO)NHCBCACO(N) HHNCOSPIN-LOCK HCANHHCC(CO) NH1H-15N NOESY-HSQC2D NOESY1H-15N HNHA15N T115N T215N-{1H} NOE
10 MM ACETIC ACID 380 MM SDS
4.5
pH
1
atm
313
K
IN ADDITION TO CLASSICAL NMR CONSTRAINTS THREE TYPES OF GLOBAL CONSTRAINTS WERE USED TO DEFINE THE GLOBAL STRUCTURE OF APO-CII IN THE APO-CII/SDS- MICELLE COMPLEX. SCRIPTS FOR THE GLOBAL STRUCTURE DETERMINATION HAVE BEEN WRITTEN AND ARE AVAILABLE UPON REQUEST. FINALLY, CNS WAS USED FOR THE FINAL MINIMIZATION.
RESTRAINT MOLECULAR DYNAMICS
1
BRUNGER
refinement
X-PLOR3.851
structure solution
XEASY
structure solution
SYBYL
structure solution
XPLOR
structure solution
CNS
600
Bruker
DRX
500
Bruker
AMX
400
Bruker
DRX
THR
1
n
1
THR
1
A
GLN
2
n
2
GLN
2
A
GLN
3
n
3
GLN
3
A
PRO
4
n
4
PRO
4
A
GLN
5
n
5
GLN
5
A
GLN
6
n
6
GLN
6
A
ASP
7
n
7
ASP
7
A
GLU
8
n
8
GLU
8
A
MET
9
n
9
MET
9
A
PRO
10
n
10
PRO
10
A
SER
11
n
11
SER
11
A
PRO
12
n
12
PRO
12
A
THR
13
n
13
THR
13
A
PHE
14
n
14
PHE
14
A
LEU
15
n
15
LEU
15
A
THR
16
n
16
THR
16
A
GLN
17
n
17
GLN
17
A
VAL
18
n
18
VAL
18
A
LYS
19
n
19
LYS
19
A
GLU
20
n
20
GLU
20
A
SER
21
n
21
SER
21
A
LEU
22
n
22
LEU
22
A
SER
23
n
23
SER
23
A
SER
24
n
24
SER
24
A
TYR
25
n
25
TYR
25
A
TRP
26
n
26
TRP
26
A
GLU
27
n
27
GLU
27
A
SER
28
n
28
SER
28
A
ALA
29
n
29
ALA
29
A
LYS
30
n
30
LYS
30
A
THR
31
n
31
THR
31
A
ALA
32
n
32
ALA
32
A
ALA
33
n
33
ALA
33
A
GLN
34
n
34
GLN
34
A
ASN
35
n
35
ASN
35
A
LEU
36
n
36
LEU
36
A
TYR
37
n
37
TYR
37
A
GLU
38
n
38
GLU
38
A
LYS
39
n
39
LYS
39
A
THR
40
n
40
THR
40
A
TYR
41
n
41
TYR
41
A
LEU
42
n
42
LEU
42
A
PRO
43
n
43
PRO
43
A
ALA
44
n
44
ALA
44
A
VAL
45
n
45
VAL
45
A
ASP
46
n
46
ASP
46
A
GLU
47
n
47
GLU
47
A
LYS
48
n
48
LYS
48
A
LEU
49
n
49
LEU
49
A
ARG
50
n
50
ARG
50
A
ASP
51
n
51
ASP
51
A
LEU
52
n
52
LEU
52
A
TYR
53
n
53
TYR
53
A
SER
54
n
54
SER
54
A
LYS
55
n
55
LYS
55
A
SER
56
n
56
SER
56
A
THR
57
n
57
THR
57
A
ALA
58
n
58
ALA
58
A
ALA
59
n
59
ALA
59
A
MET
60
n
60
MET
60
A
SER
61
n
61
SER
61
A
THR
62
n
62
THR
62
A
TYR
63
n
63
TYR
63
A
THR
64
n
64
THR
64
A
GLY
65
n
65
GLY
65
A
ILE
66
n
66
ILE
66
A
PHE
67
n
67
PHE
67
A
THR
68
n
68
THR
68
A
ASP
69
n
69
ASP
69
A
GLN
70
n
70
GLN
70
A
VAL
71
n
71
VAL
71
A
LEU
72
n
72
LEU
72
A
SER
73
n
73
SER
73
A
VAL
74
n
74
VAL
74
A
LEU
75
n
75
LEU
75
A
LYS
76
n
76
LYS
76
A
GLY
77
n
77
GLY
77
A
GLU
78
n
78
GLU
78
A
GLU
79
n
79
GLU
79
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
1
A
PRO
10
-66.76
76.14
1
A
VAL
18
-29.72
-48.52
2
A
GLN
3
-163.57
119.06
2
A
PRO
10
-63.82
94.04
2
A
VAL
18
-29.93
-51.34
2
A
PRO
43
-85.87
34.07
2
A
GLU
78
-140.83
36.30
3
A
ASP
7
-71.21
-156.52
3
A
PHE
14
-149.87
-49.03
3
A
VAL
18
-29.96
-49.34
4
A
PHE
14
-145.73
-79.89
4
A
PRO
43
-93.16
44.80
5
A
GLN
3
63.88
71.97
5
A
GLU
8
-70.15
-73.32
5
A
PHE
14
82.03
-15.63
5
A
GLU
78
-158.59
44.92
6
A
GLN
2
67.57
107.32
6
A
PHE
14
-116.80
-70.50
6
A
PRO
43
-92.99
35.35
7
A
GLN
5
-72.67
-70.60
7
A
GLN
6
-67.83
-178.39
7
A
PHE
14
-138.95
-59.51
7
A
PRO
43
-92.12
33.92
8
A
GLN
6
-67.89
73.38
8
A
PRO
12
-49.35
103.04
8
A
GLU
78
-145.03
38.50
9
A
PHE
14
-118.33
-73.27
9
A
VAL
18
-29.96
-52.66
10
A
PRO
4
-84.82
30.27
10
A
PHE
14
-149.39
-50.87
10
A
VAL
18
-29.99
-52.05
10
A
GLU
78
-168.15
-60.47
11
A
GLN
2
68.12
121.02
11
A
VAL
18
-29.73
-54.52
11
A
PRO
43
-91.50
33.83
12
A
GLN
2
-122.44
-64.41
12
A
PRO
4
-88.36
40.27
12
A
GLN
6
-67.84
-157.27
12
A
VAL
18
-29.35
-50.06
12
A
PRO
43
-92.30
48.36
13
A
GLN
2
-107.92
48.45
13
A
GLN
3
-131.05
-70.03
13
A
VAL
18
-29.54
-54.08
14
A
PHE
14
-155.87
-55.40
14
A
VAL
18
-29.58
-48.02
15
A
PRO
4
-69.90
81.08
15
A
VAL
18
-29.73
-45.94
15
A
GLU
78
-174.19
-73.16
16
A
PRO
10
-69.57
86.35
16
A
PHE
14
-154.24
-51.75
16
A
GLU
78
-172.66
-60.67
17
A
VAL
18
-29.69
-48.96
17
A
GLU
78
-142.83
36.50
18
A
GLN
2
-113.66
50.04
18
A
VAL
18
-29.79
-51.03
18
A
PRO
43
-92.97
37.55
18
A
GLU
78
-129.44
-71.45
19
A
PRO
43
-91.14
38.59
20
A
THR
13
-71.88
-87.00
20
A
PHE
14
60.34
-83.32
20
A
GLU
78
-131.27
-72.69
21
A
GLN
6
-67.75
77.39
21
A
PHE
14
-124.99
-57.02
21
A
VAL
18
-29.59
-45.24
21
A
PRO
43
-92.16
30.33
22
A
GLU
78
-140.79
-68.29
23
A
GLN
2
-155.38
44.51
23
A
GLN
6
-67.73
82.77
23
A
PHE
14
-151.54
-53.75
23
A
VAL
18
-29.99
-45.55
23
A
PRO
43
-93.64
42.70
24
A
GLN
3
71.17
146.13
24
A
PHE
14
-153.46
-59.10
24
A
GLU
78
-150.91
38.33
25
A
ASP
7
-71.03
-75.24
25
A
PRO
43
-91.18
34.94
26
A
PRO
12
-83.46
45.72
26
A
VAL
18
-29.63
-45.39
27
A
GLU
8
-70.24
-70.87
27
A
PHE
14
-150.03
-63.00
27
A
VAL
18
-29.66
-53.35
27
A
PRO
43
-92.16
31.86
28
A
GLN
3
60.83
65.54
28
A
PHE
14
-103.39
-61.28
28
A
VAL
18
-29.72
-46.55
28
A
GLU
78
-175.09
-54.36
30
A
GLN
5
-72.68
-161.45
30
A
PHE
14
73.70
-69.08
30
A
VAL
18
-29.94
-46.68
30
A
PRO
43
-88.19
43.64
31
A
GLU
8
-70.31
-74.32
31
A
PHE
14
-125.02
-60.87
31
A
VAL
18
-29.91
-53.77
31
A
PRO
43
-93.37
35.95
32
A
PRO
4
-90.22
30.78
32
A
PHE
14
-142.18
-43.19
32
A
VAL
18
-29.51
-49.18
32
A
PRO
43
-91.98
31.77
33
A
VAL
18
-29.90
-48.97
34
A
GLN
2
-103.54
52.11
34
A
GLN
6
-67.75
-73.07
34
A
VAL
18
-29.62
-45.76
34
A
PRO
43
-89.88
32.31
35
A
PHE
14
-149.54
-67.22
35
A
VAL
18
-29.83
-48.79
35
A
PRO
43
-91.41
34.41
35
A
GLU
78
-153.90
35.43
36
A
GLN
6
-67.67
-74.59
36
A
PHE
14
-107.21
-63.96
36
A
GLU
78
-170.59
-65.62
37
A
GLN
2
60.86
86.32
37
A
PRO
10
-76.81
-168.10
37
A
PRO
12
-70.05
-163.90
37
A
THR
13
-71.84
-78.08
37
A
PHE
14
69.89
-66.99
38
A
GLN
2
-109.31
-66.79
38
A
PHE
14
-122.27
-69.15
38
A
PRO
43
-93.36
42.67
39
A
GLN
3
63.75
70.78
39
A
ASP
7
-71.08
-75.03
39
A
VAL
18
-29.81
-46.96
39
A
PRO
43
-91.24
37.88
39
A
GLU
78
-173.22
-55.45
40
A
PRO
4
-67.80
82.75
40
A
GLN
6
-67.91
71.50
40
A
PRO
12
-72.96
-168.98
40
A
GLU
78
-151.06
33.25
42
A
GLN
2
71.29
142.01
42
A
THR
13
-71.91
-76.27
42
A
PHE
14
65.44
-77.96
43
A
PHE
14
-134.56
-56.67
43
A
PRO
43
-91.31
40.57
43
A
GLU
78
-146.93
38.93
44
A
PHE
14
-166.42
-61.13
44
A
VAL
18
-29.18
-50.31
44
A
PRO
43
-93.08
37.03
44
A
GLU
78
-103.86
-64.78
45
A
PHE
14
-173.40
-61.92
46
A
THR
13
-71.96
-71.67
46
A
PHE
14
60.14
-87.89
46
A
VAL
18
-29.56
-46.88
46
A
GLU
78
-152.29
36.82
47
A
GLN
6
-68.00
65.76
47
A
PHE
14
-103.72
-64.97
47
A
VAL
18
-29.99
-53.24
48
A
GLN
6
-67.99
65.84
48
A
TYR
41
-173.94
44.50
49
A
GLN
3
60.66
60.71
49
A
GLN
6
-67.81
-173.10
49
A
THR
13
-71.92
-79.13
50
A
GLN
3
-166.25
-63.20
50
A
PHE
14
-130.48
-53.52
50
A
GLU
78
-170.70
-68.00
51
A
GLN
6
24.35
-101.62
51
A
PRO
12
-68.52
-171.65
51
A
PHE
14
-131.89
-58.97
51
A
VAL
18
-29.98
-41.27
52
A
LEU
42
67.73
67.56
52
A
PRO
43
-95.14
-76.57
52
A
GLU
78
-153.83
40.17
53
A
PHE
14
-130.43
-71.14
53
A
GLU
78
-172.79
-61.94
54
A
GLN
3
-151.54
71.95
54
A
VAL
18
-29.76
-46.99
54
A
GLU
78
-172.45
-60.71
55
A
GLN
6
-67.81
-175.44
55
A
VAL
18
-29.75
-49.73
55
A
PRO
43
-90.69
34.99
55
A
GLU
78
-147.82
-62.82
56
A
PHE
14
-160.73
-52.81
57
A
GLN
2
68.09
108.21
57
A
PRO
10
-67.00
80.88
57
A
PRO
43
-92.97
36.83
57
A
GLU
78
-149.80
-61.34
58
A
GLN
3
-161.23
-62.07
58
A
GLN
6
-67.72
-177.13
59
A
PRO
4
-69.92
82.37
59
A
GLN
6
-67.81
75.16
59
A
GLU
78
-144.51
37.47
60
A
VAL
18
-29.80
-44.32
60
A
PRO
43
-92.81
36.52
61
A
GLN
2
57.37
84.51
61
A
GLN
3
-169.77
64.69
61
A
GLN
5
-72.56
-74.07
61
A
PRO
12
-66.82
91.33
61
A
PHE
14
-143.10
-62.02
61
A
GLU
78
-173.34
-55.13
62
A
GLN
6
-67.81
-176.44
62
A
PRO
12
-54.57
105.88
62
A
PHE
14
-106.18
-66.24
63
A
PRO
10
-72.52
-167.76
63
A
PHE
14
-168.28
-65.55
63
A
VAL
18
-29.52
-55.48
63
A
GLU
78
-74.38
-74.31
64
A
PHE
14
79.80
-43.84
64
A
VAL
18
-29.45
-45.99
64
A
PRO
43
-92.53
41.30
65
A
GLN
6
-67.87
71.88
65
A
PHE
14
-125.89
-63.89
65
A
PRO
43
-92.67
40.31
65
A
VAL
45
-27.78
-65.55
65
A
GLU
78
-149.00
38.30
66
A
LEU
42
41.93
72.27
66
A
PRO
43
-92.75
-69.98
66
A
GLU
78
-147.30
33.90
67
A
GLN
6
-67.87
67.79
67
A
PRO
12
-79.03
-159.42
67
A
PHE
14
84.23
-49.53
67
A
VAL
18
-29.97
-50.49
67
A
PRO
43
-93.38
-62.34
67
A
GLU
78
-74.50
-76.58
68
A
GLN
3
-170.65
-61.13
68
A
TYR
41
-65.78
-79.65
68
A
LEU
42
174.37
-54.09
68
A
VAL
45
-42.72
-77.00
APOLIPOPROTEIN C-II
Global Structure and Dynamics of Human Apolipoprotein CII in Complex with Micelles: Evidence for increased mobility of the helix involved in the activation of lipoprotein lipase
1
N
N
A
THR
16
A
THR
16
HELX_P
A
GLU
38
A
GLU
38
1
1
23
A
VAL
45
A
VAL
45
HELX_P
A
ALA
58
A
ALA
58
1
2
14
A
THR
64
A
THR
64
HELX_P
A
VAL
74
A
VAL
74
1
3
11
LIPID TRANSPORT
APOCII, LPL, ACTIVATION MECHANISM, DOMAIN MOTION, SDS, MICELLE, GLOBAL STRUCTURE, LOCAL STRUCTURE, DYNAMICS, HELIX, LIPID TRANSPORT, LIPID DEGRADATION, CHYLOMICRON
APC2_HUMAN
UNP
1
P02655
23
101
1O8T
1
79
P02655
A
1
1
79
1
P 1